Pfizer News Stories
News about Pfizer updated daily from the top business, technology news sources
nobosh has recorded 169 news stories about Pfizer
Tagged 1 Day + (500 Max)
-
What Should Pfizer Buy? -
1 day ago
Own All These Drug Stocks - 2 days ago
IT Research Firm TheInfoPro Gets $7.25 Million Funding - 2 days ago
They Just Don't Get Pfizer! - 4 days ago
S&P Picks and Pans: Apple, Synovus, Peabody Energy, Pfizer, Rohm & Haas, Varian - 4 days ago
Pfizer's Potential Buys, Big and Small - 4 days ago
Pfizer chief open to acquisitions: report - 4 days ago
Pfizer Open to Buying Drug Rivals: Report - 4 days ago
3 Stocks I Saw on TV - 11 days ago
Pfizer Becomes Auxilium's European Envoy - 21 days ago
Auxilium Seals Deal With Pfizer - 22 days ago
Eli Lilly Raises, Pfizer Declares, Dividends - 25 days ago
The case for Pfizer - 1 month ago
The case for Pfizer's stock - 1 month ago
Five Dumbest Things on Wall Street: Nov. 28 - 1 month ago
Viagra Stays Behind EU Counters - 1 month ago
Before the Bell: Citigroup, Pfizer, General Electric in the spotlight - 1 month ago
Pfizer pulls E.U. application to sell Viagra over the counter - 1 month ago
Movers & Shakers: Thursday's biggest gaining and declining stocks - 1 month ago
Analysts' Upgrades, Downgrades: Pfizer - 1 month ago
Pfizer Opening Stem-Cell Unit - 1 month ago
Tim Brown: Move Forward With Pfizer - 2 months ago
Rumors of a Pfizer Bid Push Bayer Shares Up - 2 months ago
Bayer shares gain on market talk of Pfizer bid - 2 months ago
Pfizer's Prescription Needs Adjusting - 2 months ago
Pfizer's Okay For Now But Pressures Loom - 2 months ago
S&P Picks and Pans: Ford, AmEx, Texas Instruments, Pfizer - 2 months ago
Pfizer Narrows Full-Year Forecast - 2 months ago
Biotech Stocks: Drug stocks head south while Pfizer, Schering-Plough go north - 2 months ago
Pfizer Q3 profit triples due to charge last year; revenue slips - 2 months ago
NewsWatch: U.S. stock futures slip before earnings wave - 2 months ago
Pfizer's profit triples after last year's insulin product hit - 2 months ago
Before the Bell: Pfizer, DuPont, Caterpillar, Ford and more in the spotlight - 2 months ago
Indications: U.S. stock futures slip before earnings wave - 2 months ago
Get in Shape for Earnings Season: AmEx, Cat, Pfizer - 2 months ago
Pfizer Finds Redemption - 2 months ago
$894M deal ends most of Pfizer's lawsuits - 2 months ago
Pfizer to settle Bextra, Celebrex lawsuits - 2 months ago
Pfizer Settles Pain Drug Cases for $894M - 2 months ago
Pfizer to take $894 million charge for legal settlement - 2 months ago
Earnings Outlook: Pfizer seen as reporting higher earnings, but lackluster sales - 2 months ago
Pfizer Sues Viva Viagra Rocket Crackpot Over Trademark - 2 months ago
More Changes Brewing At Pfizer - 3 months ago
10 Gadgets to Help You Survive the Coming Economic Apocalypse - 3 months ago
Pfizer Dropping Heart Drugs; Focus on Cancer - 3 months ago
Pfizer shifts focus,, ends new research on heart disease - 3 months ago
Pfizer says R&D pipeline advancing ahead of schedule - 3 months ago
Before the Bell: Pfizer, Huntsman, Sovereign, Genworth in the spotlight - 3 months ago
Pfizer To Abandon Heart Drugs: Report - 3 months ago
Pfizer to end heart, obesity drug development - 3 months ago
Corrections: Biotech stocks rally; Pfizer, Novartis gain - 3 months ago
Biotech Stocks: Biotech stocks rally; Pfizer, Novartis gain - 3 months ago
Pfizer launches new website on medication safety - 3 months ago
Long-Tail Economics? Give Me Blockbusters! - 3 months ago
Pfizer Fever Buoys Bayer - 4 months ago
Movers & Shakers: Tuesday's biggest gaining and declining stocks - 4 months ago
Rumors of a Pfizer Deal Lift Bayer Shares - 4 months ago
Bayer rises on talk of Pfizer interest: traders - 4 months ago
Pfizer Awaits Fablyn Probe - 4 months ago
FDA Board Questions Pfizer's Fablyn - 4 months ago
FDA staff note deaths in Pfizer bone drug study - 4 months ago
Pfizer Bets On Alzheimer's Drug - 4 months ago
Pfizer gains rights to Medivation Alzheimer's drug - 4 months ago
Pfizer Licenses Medivation Alzheimer's Drug - 4 months ago
Movers & Shakers: Wednesday's biggest gaining and declining stocks - 4 months ago
Health Winners & Losers: Pfizer - 4 months ago
Movers & Shakers: Monday's biggest gaining and declining stocks - 4 months ago
Nicox says Pfizer drops glaucoma drug study in Asia - 4 months ago
Marcial: Drugmaker Pfizer, a 'Fallen Angel?' - 5 months ago
Avoid Value Traps Like Merck and Pfizer - 5 months ago
Pfizer Leans On Lipitor, Cost Cutting - 5 months ago
S&P Picks and Pans: Fannie Mae, Freddie Mac, Yahoo, WaMu, Pfizer, Travelers, AT&T, Alcatel-Lucent - 5 months ago
Top drug companies' earnings beat forecasts - 5 months ago
Pfizer Beats EPS Target by a Penny - 5 months ago
Pfizer profit doubles, but anti-smoking drug lags - 5 months ago
Today's Earnings: AT&T, Boeing - 5 months ago
Pfizer earnings more than double - 5 months ago
Pfizer's profit doubles on lower costs, favorable exchange rate - 5 months ago
Analyst Says Bristol-Myers A Buyout Target - 6 months ago
Pfizer Launches Major Agency Review, Denies Consolidation - 6 months ago
Pfizer Launches Major Review - 6 months ago
Pfizer's Chantix Woes Bash Blockbuster Hopes - 6 months ago
India's Ranbaxy falls nearly 7 percent after Lipitor deal - 6 months ago
Pfizer shares rise on generic Lipitor deal - 6 months ago
Biotech Stocks: Drug stocks mixed; Pfizer climbs on Lipitor deal - 6 months ago
Before the Bell: Morgan Stanley, FedEx, Fifth Third, Pfizer in the spotlight - 6 months ago
Lipitor patent settlement allows U.S. generic in 2011 - 6 months ago
Pfizer settlement slows generic Lipitor - 6 months ago
Ranbaxy, Pfizer settle Lipitor patent disputes - 6 months ago
Drug Companies Adopt Tighter Rules on Ads - 6 months ago
Pfizer Makes A Play To Keep Lipitor - 6 months ago
Why Pfizer Might Want Ranbaxy - 6 months ago
Pfizer May Table Counter-Bid for India's Ranbaxy, Report Says - 6 months ago
Pfizer Inc. may make counter bid for Ranbaxy: report - 6 months ago
Pfizer may make counter bid for Ranbaxy: report - 6 months ago
Marcial: The Formula for a Pfizer Recovery - 7 months ago
Pfizer names new general counsel - 7 months ago
S&P Picks and Pans: Ford, NetApp, Pfizer, GameStop, Burger King - 7 months ago
FAA bans Pfizer's Chantix for flight personnel - 7 months ago
FAA Bans Pilot Use of Pfizer's Chantix - 7 months ago
FAA bans Pfizer anti-smoking drug - 7 months ago
Pfizer's Chantix Going Up In Smoke - 7 months ago
Fora.TV Gets $4 Million First Round For Intelligent Video Programming - 8 months ago
Biotech Stocks: Pfizer, AstraZeneca lead drug stocks lower - 8 months ago
First Look: May 6, 2008 - 8 months ago
Pfizer drops glaucoma drug, NicOx shares slump - 8 months ago
Pfizer reaches deal with some Celebrex users: report - 8 months ago
Esperion Raises $22.8 Million After Pfizer Spin-Out - 8 months ago
Pfizer invests $300 mln in Irish biotech facility - 8 months ago
Dykstra's Deep-in-the-Money Call: Pfizer - 8 months ago
Biotech Stocks: Drug shares rise with broader market, Pfizer rebounds - 8 months ago
Pfizer Flops - 8 months ago
Stocks Stagger Back to Midline - 8 months ago
You Ask, Peltier Answers - 8 months ago
NewsWatch: U.S. stocks fall after mixed earnings, data - 8 months ago
NewsWatch: U.S. stock futures lower after Wednesday's rally - 8 months ago
Pfizer earnings fall 18% as drug sales slide - 8 months ago
Pfizer posts 18% drop in first-quarter profit; revenue off 5% - 8 months ago
Before the Bell: Merrill Lynch, IBM, eBay, Pfizer, Roche, Google in focus - 8 months ago
Pfizer's quarterly profit sinks 18% - 8 months ago
Pfizer earnings fall 18 percent - 8 months ago
Pfizer, Avant Ink R&D Deal for Cancer Vaccine - 8 months ago
Pfizer updates inhaled-insulin label; link to lung cancer eyed - 9 months ago
Biotech Stocks: Mannkind, Nektar battered by Pfizer warning - 9 months ago
Pfizer warns of lung cancer with inhaled insulin - 9 months ago
Pfizer Scraps Trial, Investors Worry Medarex Next - 9 months ago
Pfizer's Melanoma Failure Will Hit Others - 9 months ago
Congress Expands Probe of Prescription-Drug Ads - 9 months ago
Encysive Makes Pfizer's Blood Pressure Rise - 9 months ago
Pfizer Foils Generic Ambitions For Lipitor - 9 months ago
Target's inner circle - 9 months ago
Shire as bid target: could it say no to AstraZeneca, Pfizer? - 9 months ago
Shire up on market talk of Pfizer interest: traders - 9 months ago
Pfizer Protects Celebrex Patent From Teva - 10 months ago
Pfizer, Bristol-Myers lead drug stocks lower - 10 months ago
Pfizer plans to ramp up outsourcing - 10 months ago
Pfizer aims to expand in emerging markets - 10 months ago
Pfizer exec gets bail in Nigeria trial over drug - 10 months ago
Justices split in Pfizer drug fraud case - 10 months ago
Pfizer Yanks Lipitor Ad - 10 months ago
Pfizer pulls Lipitor ads featuring artificial heart inventor - 10 months ago
Pfizer drops Lipitor ads after attack - 10 months ago
Looking for Next Big Hit, Pfizer Spends $195 Million on Encysive - 10 months ago
Pfizer Has Its Heart On Its Sleeve - 10 months ago
Encysive Snags a Buyer - 10 months ago
Pfizer to buy Encysive for $195 million - 10 months ago
Pfizer drug linked to higher heart failure rate - 10 months ago
Shock to the system - 11 months ago
Big Pharma Moving More Work Offshore - 11 months ago
Pfizer Q4 profit, sales top forecast - 11 months ago
Stocks struggle in early trade - 11 months ago
Pfizer reports lower quarterly net income due to year-ago gain - 11 months ago
Pfizer beats profit forecast; shares jump - 11 months ago
Pfizer sales, earnings beat estimates - 11 months ago
Wednesday's biggest gaining and declining stocks - 11 months ago
Stocks in focus for Wednesday - 11 months ago
Rate Cut Prelude To Wednesday Earnings - 11 months ago
Pfizer Boosts Caution On Anti-Smoking Drug - 11 months ago
Pfizer says ruling favorable in NY Celebrex case - 12 months ago
UPDATE 2-US House panel says probing Pfizer Lipitor ads - 12 months ago
Glaxo says Advair shows edge over Spiriva in COPD - 12 months ago
Nigeria court seeks 3 arrests in Pfizer drug trial - 12 months ago
Novartis to cut 2,500 jobs, joining rivals including Pfizer - 12 months ago
Fitch downgrades some Pfizer debt - 12 months ago
OFT sees risks in exclusive drug distribution deals - 12 months ago